Overview
Portfolio
More
Atria Ventures
San Francisco, United States
Atria Ventures invests in early‑stage life‑science companies, focusing on computational biology platforms, AI infrastructure, and vertical software that accelerate drug discovery and healthcare delivery. The firm aims to...
Portfolio
17+
Employees
<3
Founded
N/A
AUM
≈ $20.2M
Investment focus
Stages
Pre-Seed → Seed
Industries
Artificial IntelligenceBiotechnologyDigital HealthHealthcare Technology
Geographic scope
United States
Fund details
Funds
Fund I L.P
Vintage 2024 • $20.2M
Check sizes
Min: $250.0K
Typical: $625.0K
Max: $1.0M
Sources
Atria Ventures
Atria Ventures invests in early‑stage life‑science companies, focusing on computational biology platforms, AI infrastructure, and vertical software that accelerate drug discovery and healthcare delivery. The firm aims to partner with outlier founders at the inception and seed stages to unlock business development, licensing, and distribution opportunities.
Portfolio
17+
Employees
<3
Founded
N/A
AUM
≈ $20.2M
Funds
Fund I L.P · Vintage 2024 • $20.2M
Check Sizes
Min: $250.0K
Typical: $625.0K
Max: $1.0M
Stages
Pre-Seed → Seed
Industries
Artificial IntelligenceBiotechnologyDigital HealthHealthcare Technology
Geographic scope
United States
Sources
Showing 17 of 17 matched portfolio companies
Abridge provides an enterprise‑grade generative AI platform that listens to patient‑clinician conversations and creates real‑time, context‑aware clinical notes directly within Epic’s workflow. The system leverages prior encounter data, health‑system guidelines, and billing code alignment to produce compliant, billable documentation across specialties and languages, reducing clinician workload and closing revenue‑cycle gaps.
Funding: $300.0M
Rough estimate of the amount of funding raised
Funding: $300.0M
Rough estimate of the amount of funding raised
Axiom Bio provides an AI-driven translational intelligence platform that predicts human drug toxicity by linking extensive human-relevant experimental data to clinical outcomes. The service offers mechanistic risk assessmentsand early toxicity signals to pharmaceutical scientists, enabling more informed decision‑making and reducing late‑stage drug failures. Revenue is generated through subscription‑based access to the predictive models and risk assessment reports for drug development programs.
This company provides an AI platform designed to assist enterprise compensation teams with pay decisions using proprietary market data. The platform features AI agents that analyze market trends for compensation analysts and scale expertise for HR and recruiting stakeholders. It integrates with existing HR infrastructure to ensure accurate, real-time compensation alignment with company strategy.
Funding: $24.0M
Rough estimate of the amount of funding raised
Funding: $24.0M
Rough estimate of the amount of funding raised
This startup develops consumer products that utilize molecular and biological science to enhance healthspan and wellbeing through preventative health solutions. By providing accessible and effective tools, the company empowers individuals to take control of their health and longevity.
HairDAO operates an open-source research and development network connecting patients and researchers focused on developing new hair loss treatments. Community members contribute treatment data and participate in governance by holding the HAIR token to fund promising research projects. This decentralized approach aims to accelerate the discovery of effective therapies for androgenetic alopecia and related conditions.
Funding: $3.3M
Rough estimate of the amount of funding raised
Funding: $3.3M
Rough estimate of the amount of funding raised
HoX provides a programmable computational stack designed to structure and integrate heterogeneous biological data across various assays and instruments. This platform enables users to run sequencing operations and perform complex analysis, such as cell visualization and genomic browsing, directly within the system. By making biology computable, HoX accelerates scientific discovery by unifying disparate data sources into actionable insights.
Lighten provides trustworthy AI solutions that generate superior results from complex clinical data with regulatory-grade precision. The platform instantly curates real patient journeys, validating complete histories including symptoms, treatments, and outcomes from unstructured notes and structured fields. This enables healthcare and life sciences organizations to efficiently recognize and target specific patient cohorts for research and commercial needs.
Funding: $5.5M
Rough estimate of the amount of funding raised
Funding: $5.5M
Rough estimate of the amount of funding raised
Molecule is a funding and tokenization platform that utilizes blockchain technology to streamline the financing of biopharma intellectual property and decentralized science projects. By enabling researchers to access funding quickly and transparently, Molecule addresses the inefficiencies and barriers in traditional scientific funding models, fostering innovation in the pharmaceutical industry.
Funding: $7.5M
Rough estimate of the amount of funding raised
Shine Capital
Shine Capital
Funding: $7.5M
Rough estimate of the amount of funding raised
Orchestra is an agentic operations platform that unifies R&D planning, financial modeling, and decision support for biotech and pharmaceutical drug development teams. It provides a centralized visual roadmap, integrated budgeting tools, and AI‑driven analytics to align scientific programs with executive goals, automate resource allocation, and deliver real‑time performance insights across the organization.
Funding: $4.0M
Rough estimate of the amount of funding raised
Funding: $4.0M
Rough estimate of the amount of funding raised
Peer AI provides a unified, AI‑driven platform that assists regulatory affairs teams in drafting, reviewing, and submitting drug development dossiers. Specialized generative AI agents produce high‑quality text for all document types—from IND modules to Phase 3 CSR and safety narratives—while end‑to‑end traceability links each output to its source data and predictive analytics flag likely reviewer questions, enabling proactive revisions and faster, more reliable submissions.
Funding: $12.1M
Rough estimate of the amount of funding raised
+ 5 Other investorsFlare Capital PartnersSignalFire
+ 5 Other investorsFlare Capital PartnersSignalFire
Funding: $12.1M
Rough estimate of the amount of funding raised
Platform is an online marketplace that collaborates with contemporary artists and galleries to offer unique artworks, artist-designed products, and fine art prints, ensuring a curated selection of collectible items. By providing access to exclusive pieces priced at $2,500 and under, Platform addresses the challenge of affordability and accessibility in the contemporary art market.
Funding: $2.6M
Rough estimate of the amount of funding raised
Funding: $2.6M
Rough estimate of the amount of funding raised
ReSync Bio provides a centralized platform that integrates laboratory data, AI models, and collaborative workflows for biopharmaceutical companies. This solution eliminates manual bottlenecks and data silos, enabling faster decision-making and streamlined preclinical operations.
5+
200+Approximate amount of employees
This company provides on-demand strategic biopharma intelligence by leveraging a vast, proprietary database of structured data, filings, and research documents. They offer competitive landscape analysis, custom briefings, and integration of internal data to support decision-making regarding indication prioritization and market positioning. The platform ensures data security and provides auditable citations for all generated insights.
Funding: $7.7M
Rough estimate of the amount of funding raised
Funding: $7.7M
Rough estimate of the amount of funding raised
Specie Bio operates an AI-driven platform that connects researchers with global providers of biological samples and multimodal medical data. This streamlined process facilitates the exchange of samples and data rapidly, significantly accelerating scientific research and development timelines. The platform enables users to efficiently source diverse assets, including genomics, imaging, and clinical data, from a trusted network of health systems and biobanks.
5+
100+Approximate amount of employees
Tandem offers an AI‑driven platform that automates the medication access workflow—including prior authorization submission, appeal generation, enrollment, and pharmacy routing—directly from the provider’s EHR. The system provides real‑time status tracking, secure notifications, and a financial‑assistance engine to match patients with cost‑saving options, eliminating manual paperwork and reducing administrative overhead at no cost to providers or patients.
This AI-powered platform automates patient identification and recruitment for clinical trials by integrating with electronic health records. It helps research sites accelerate enrollment, reduce screen failures, and improve operational efficiency, ultimately speeding up the development of new therapies.
Provides a project management platform tailored for creative teams to organize, review, and collaborate on digital assets like designs, videos, and websites. It streamlines feedback loops by enabling real-time comments, version tracking, and AI-driven error detection, reducing the need for meetings and improving project efficiency.
25+
700+Approximate amount of employees
Funding: $3.0M
Rough estimate of the amount of funding raised
Venrex
Venrex
Funding: $3.0M
Rough estimate of the amount of funding raised